BRITTANY AXNER: Open Payments
NPI 1194133108 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 73 payments from 16 companies in 2025. Trend: 2023 $1,761 · 2024 $1,380 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $275 |
| UCB, Inc. | 9 | $208 |
| Novartis Pharmaceuticals Corporation | 6 | $161 |
| Janssen Biotech, Inc. | 12 | $145 |
| Amgen Inc. | 4 | $96 |
| GENZYME CORPORATION | 3 | $92 |
| LEO Pharma Inc. | 5 | $91 |
| PFIZER INC. | 5 | $90 |
| Arcutis Biotherapeutics, Inc. | 3 | $58 |
| Incyte Corporation | 2 | $57 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, COSENTYX, Otezla, CIBINQO.
Industry payments across NC — which companies pay providers there.
